Overall, these results indicate that inhibiting IL-10 production during vaccination improves vaccine efficacy against subsequent s.c. S. aureus infection, due to enhanced T cell responses at the site of infection in combination with enhanced IL-1β production, both of which are central to effective bacterial clearance. The gene discussed is IL1B; the disease is infection.